This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23,
Boston Convention and Exhibition Center

THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS

Access novel science, technologies and contacts to improve efficiencies across the entire spectrum of biopharmaceutical development and production

Early Registration Deadline Approaching

Register for the In-Person All Access or Digital Experience Pass by Friday, June 25 to Save Up to $800/person.  

Questions? Contact Event Marketing Manager Howie Choi at howard.choi@informa.com

Access Novel Science Across the Entire Bioprocessing Spectrum

Our BPI 2021 agenda includes 9 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies.  Your registration provides access to the presentations across all 9 tracks, allowing you to create an agenda tailored specifically for your needs.


Manufacturing Strategy & Bioprocessing 4.0
Manufacturing Strategy & Bioprocessing 4.0

Apply digital technologies, artificial intelligence and machine learning to increase manufacturing efficiency through smart and data-driven bioprocessing.

Cell Culture & Upstream Processing
Cell Culture & Upstream Processing

Optimize speed, titers, efficiency and quality in upstream process development.

Recovery & Purification
Recovery & Purification

Apply novel technologies that are enabling next generation downstream processes to overcome bottlenecks and optimize manufacturing, quality and control of emerging modalities.


Analytical & Quality
Analytical & Quality

Achieve a high quality product using optimal analytical strategies while reducing timelines. 

Intensified & Continuous Processing
Intensified & Continuous Processing

Accelerate manufacturing timelines by achieving intensified and fully continuous processing from the development, optimization and implementation of novel technologies, analytical tools and automated systems.

Speed from Gene to Market
Speed from Gene to Market

Gain the industry insights you need to accelerate speed and compress timelines to IND and BLA submissions.


Cell Therapy
Cell Therapy

Build your analytical toolbox to improve testing, characterization & validation strategies


Gene Edited Ex Vivo Cell Therapy
Gene Edited Ex Vivo Cell Therapy

Overcome autologous and allogeneic manufacturing challenges with novel modalities, gene editing and more


In Vivo Gene Therapy
In Vivo Gene Therapy

Learn about next generation cells lines, production optimization & novel platforms


Lars Pampel, Ph.D., Head, Process Sciences, Technical Development, New Biological Entities, Novartis, Switzerland

DataHow

“BPI brings leading thoughts and discussion to a balanced audience of scientists and decision makers.”

CONNECT WITH KEY BUYERS BY BECOMING A BPI SPONSOR/EXHIBITOR

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals in today's virtual environment.

(Companies A-L) Contact Jennifer Wickett: Jennifer.Wickett@informa.com | +1-857-504-6694 

(Companies M-Z) Contact Blake Shuka: Blake.Shuka@informa.com | +1-857-504-6684